MTOR Gene: Structure, Function, and Clinical Significance

A comprehensive overview of the MTOR gene, its protein product, associated diseases, and expression patterns.

Gene Information Card

Symbol MTOR
Full Name mechanistic target of rapamycin kinase
Gene Type protein coding
Chromosomal Location 1p36.22
NCBI Gene ID 2475 ncbi.nlm.nih.gov/gene/2475
Ensembl ID ENSG00000198793
UniProt ID P42345
OMIM ID 601231
HGNC ID 3942
Aliases FRAP, FRAP1, FRAP2, RAFT1, RAPT1

Description

The MTOR gene encodes the mechanistic target of rapamycin (mTOR), a serine/threonine kinase that serves as a central regulator of cell growth, proliferation, motility, survival, and protein synthesis. It integrates signals from growth factors, nutrients, and cellular energy status to modulate cellular metabolism. mTOR is a key component of two distinct complexes, mTORC1 and mTORC2, which have different substrates and functions. Dysregulation of MTOR is implicated in various cancers, metabolic disorders, and developmental syndromes.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (multiple types) Activating mutations or amplification of MTOR lead to constitutive activation of mTORC1, promoting uncontrolled cell growth and proliferation. COSMIC; ClinVar
Smith-Kingsmore syndrome Germline gain-of-function mutations in MTOR cause macrocephaly, intellectual disability, and distinctive facial features. OMIM; ClinVar
Focal cortical dysplasia (type II) Somatic MTOR mutations in brain tissue cause abnormal neuronal migration and cortical malformations, leading to epilepsy. ClinVar; literature
Leiomyosarcoma MTOR mutations or pathway activation contribute to tumor progression and resistance to apoptosis. COSMIC
Perivascular epithelioid cell tumors (PEComas) Loss-of-function mutations in TSC1/TSC2 or activating MTOR mutations lead to mTORC1 hyperactivation, driving tumor growth. ClinVar; literature

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.4 High
Muscle 8.2 Medium
Liver 7.5 Medium
Kidney 6.9 Medium
Lung 5.8 Low
Heart 5.5 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.3 High expression; commonly used in mTOR studies
A549 10.1 Moderate expression; lung carcinoma
MCF7 9.8 Moderate expression; breast cancer
HepG2 8.4 Moderate expression; liver cancer
K562 6.2 Low expression; leukemia
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.M2327I Missense 0.5% Gain-of-function; increases kinase activity
p.S2215Y Missense 0.3% Gain-of-function; associated with focal cortical dysplasia
p.E2419K Missense 0.2% Gain-of-function; found in cancer
p.R2505P Missense 0.1% Gain-of-function; linked to Smith-Kingsmore syndrome
p.L1460P Missense 0.1% Loss-of-function; reduces kinase activity
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in MTOR are rare and typically result in reduced kinase activity, leading to impaired cell growth and proliferation. These may be associated with developmental defects.

Gain of Function (GOF)

Gain-of-function mutations are more common and lead to hyperactivation of mTORC1, promoting tumorigenesis, abnormal cell growth, and cortical malformations.

Dominant Negative (DN)

Dominant-negative mutations have not been well-characterized for MTOR; most mutations are either activating or inactivating.

Gene Ontology (GO)

• protein kinase activity • ATP binding
• signal transduction • regulation of cell growth
• response to nutrient levels • TORC1 complex
• TORC2 complex

Pathways

PI3K/AKT/mTOR pathway
mTOR signaling pathway
Insulin signaling pathway
Autophagy regulation
Cell cycle regulation

Protein Summary

The mTOR protein is a large (289 kDa) serine/threonine kinase that forms two distinct complexes: mTORC1 (with Raptor, mLST8, and PRAS40) and mTORC2 (with Rictor, mLST8, and SIN1). mTORC1 is rapamycin-sensitive and regulates protein synthesis, autophagy, and lipid biogenesis in response to growth factors and amino acids. mTORC2 is rapamycin-insensitive and controls cell survival and cytoskeletal organization by phosphorylating AKT and other targets. The protein contains multiple domains including HEAT repeats, FAT domain, FRB domain, kinase domain, and FATC domain. Its activity is tightly regulated by upstream signals such as PI3K/AKT, AMPK, and amino acid sensing via Rag GTPases.

Related Products

Product name Cat.No. Species Gene ID
LAMTOR1 Knockout HEK293 Cell Line EDJ-KQ1147 Human 55004 Details Get a Quote
LAMTOR4 Knockout HEK293 Cell Line EDJ-KQ1148 Human 389541 Details Get a Quote
LAMTOR5 Knockout HEK293 Cell Line EDJ-KQ1149 Human 10542 Details Get a Quote
LAMTOR5 Knockout A-549 Cell Line EDJ-KQ19031 Human 10542 Details Get a Quote
LAMTOR1 Knockout A-549 Cell Line EDJ-KQ20369 Human 55004 Details Get a Quote
LAMTOR1 Knockout HCT 116 Cell Line EDJ-KQ20370 Human 55004 Details Get a Quote
LAMTOR1 Knockout HeLa Cell Line EDJ-KQ20371 Human 55004 Details Get a Quote
LAMTOR4 Knockout HCT 116 Cell Line EDJ-KQ20372 Human 389541 Details Get a Quote
LAMTOR4 Knockout HeLa Cell Line EDJ-KQ20373 Human 389541 Details Get a Quote
LAMTOR5 Knockout HCT 116 Cell Line EDJ-KQ20375 Human 10542 Details Get a Quote
LAMTOR5 Knockout HeLa Cell Line EDJ-KQ20376 Human 10542 Details Get a Quote
SAMTOR Knockout A-549 Cell Line EDJ-KQ41557 Human 154743 Details Get a Quote
SAMTOR Knockout HCT 116 Cell Line EDJ-KQ41558 Human 154743 Details Get a Quote
SAMTOR Knockout HeLa Cell Line EDJ-KQ41559 Human 154743 Details Get a Quote
Lamtor5 Knockout 4T1 Cell Line EDJ-KZ322 Mouse 68576 Details Get a Quote
Displaying Records 1 To 15 Of 26 Records
Contact Us
*
*
*
*
How did you hear about us: